43
Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to an immunotherapy drug, a clinical trial suggests.
This is the first sign of a breakthrough for patients with this difficult-to-treat cancer for 20 years, say scientists behind the research.
Laura Marston, 45, from Derbyshire, says she is "amazed she's still here" after being given "dire" chances of survival following a diagnosis of advanced tongue cancer six years ago.
She received the immunotherapy before and after surgery, which researchers say helps the body learn to attack the cancer if it returns.
